Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.
Tubita A, Lombardi Z, Tusa I, Lazzeretti A, Sgrignani G, Papini D, Menconi A, Gagliardi S, Lulli M, Dello Sbarba P, Esparís-Ogando A, Pandiella A, Stecca B, Rovida E. Tubita A, et al. Among authors: esparis ogando a. Cancer Res. 2022 Feb 1;82(3):447-457. doi: 10.1158/0008-5472.CAN-21-0993. Epub 2021 Nov 19. Cancer Res. 2022. PMID: 34799355 Free PMC article.
Therapeutic potential of ERK5 targeting in triple negative breast cancer.
Ortiz-Ruiz MJ, Álvarez-Fernández S, Parrott T, Zaknoen S, Burrows FJ, Ocaña A, Pandiella A, Esparís-Ogando A. Ortiz-Ruiz MJ, et al. Oncotarget. 2014 Nov 30;5(22):11308-18. doi: 10.18632/oncotarget.2324. Oncotarget. 2014. PMID: 25350956 Free PMC article.
Targeting the EGF/HER Ligand-Receptor System in Cancer.
Esparís-Ogando A, Montero JC, Arribas J, Ocaña A, Pandiella A. Esparís-Ogando A, et al. Curr Pharm Des. 2016;22(39):5887-5898. doi: 10.2174/1381612822666160715132233. Curr Pharm Des. 2016. PMID: 27426127 Review.
42 results